Skip to main content

OIG Opines on Subsidizing Medicare Cost-Sharing for Clinical Trials

By The National Law Review  
   February 26, 2024

The Office of Inspector General (OIG) opined that it will not impose administrative sanctions against a clinical trial sponsor covering up to $2,000 of a clinical trial participant’s cost-sharing obligations.

Full story

Get the latest on healthcare leadership in your inbox.